https://www.wired.com/story/alzheimers-drugs-benefits-risks-lecanemab-donanemab/
0
0
5/24/23 at 11:00am
Organization
Wired
Author
Grace Huckins
Antibody treatments clear amyloid protein from patients' brains, slowing the progression of their disease but potentially inducing deadly swelling.
Create an account
or login to join the discussion